LISA FLORES-ROSAS: Open Payments
NPI 1487136602 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 21 payments from 10 companies in 2025. Trend: 2023 $147 · 2024 $455 · 2025 $1,160
Food & beverage: $565Consulting: $500Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $700 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| SEAGEN INC. | 1 | $95 |
| Janssen Biotech, Inc. | 2 | $48 |
| Genmab U.S., Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Eisai Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Syndax Pharmaceuticals, Inc. | 1 | $27 |
Products named: ELAHERE, KEYTRUDA, Tivdak, Onivyde, LYNPARZA, Lenvima, JEMPERLI, DARZALEX.
Industry payments across TX — which companies pay providers there.
